Coşkun, AbdurrahmanÖzdemirli, BurcuMemişoğulları, Ramazan2020-04-302020-04-3020071300-0144https://hdl.handle.net/20.500.12684/4193Coskun, Abdurrahman/0000-0002-1273-0604WOS: 000254130800010In this study, we aimed to investigate the role of pregnancy-associated plasma protein-A (PAPP-A) as insulin-like growth factor binding protein-4 (IGFBP-4) protease in epilepsy patients. We studied 16 epilepsy patients and 10 healthy controls. Serum PAPP-A levels of epilepsy patients (6.8 +/- 3.2 mU/L) were higher than of the control group (5.1 +/- 1.9 mU/L), but the difference was not statistically significant (P > 0.05). We concluded that PAPP-A may increase the bioavailability of insulin-like growth factors (IGFs) due to decreased neurogenesis and synthesis of IGFs in chronically epilepsy patients.eninfo:eu-repo/semantics/closedAccessbrain tumorepilepsyIGF-IIGFBPICFBP-4neurogenesisPAPP-AArticle3714546Q3N/A